Replimune Group's market cap is currently $362.96M. The company's EPS TTM is $-0.95; its P/E ratio is ―; Replimune Group is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
